After Pfizer and Moderns, another promising news, a potential coronavirus vaccine developed by AstraZeneca Plc and Oxford University has produced a strong immune response in older adults. Giving hope that it may protect some of those most vulnerable to coronavirus,…

Oxford’s Covid-19 vaccine candidate prompts an immune response in both young and old adults, AstraZeneca Plc said on Monday. The Anglo-Swedish drugmaker is collaborating with the University of Oxford for the manufacturing of its ChAdOx1 vaccine for coronavirus. Subscribe to…